Teladoc Enhances Virtual Sitter With AI for Improved Care Delivery

26.11.24 19:31 Uhr

Werte in diesem Artikel
Aktien

2.093,00 JPY -11,00 JPY -0,52%

9,07 EUR 0,05 EUR 0,53%

Teladoc Health, Inc. TDOC upgraded its Virtual Sitter solution by infusing new AI-powered enhancements. The enhanced solution is now available commercially and has already been adopted by select clients. The TDOC solution employs sophisticated, pre-trained algorithms, motion detection and pose estimation to identify patient movements that may lead to falls, allowing for quicker responses by bedside staff. The new technology, integrated within Teladoc’s TV Pro devices, utilizes local processing power to bolster the security of Protected Health Information and enhance system performance.The usage of AI technology enables a single remote staff member to oversee up to 25% more patients. This, in turn, is expected to expand the capacity of healthcare inpatient teams, elevate patient safety, mitigate workforce challenges and improve care delivery across hospitals and health systems.The recent announcement also seems to be a time opportune one since around 1 million hospitalized patients suffer from falls annually, with more than 30% sustaining serious injuries. The CDC reports that these incidents incur about $50 billion in medical expenses each year, further burdening hospitals.Rationale Behind the Latest MoveThe latest advancement to the Virtual Sitter solution is part of Teladoc’s efforts to upgrade its suite of inpatient connected care solutions that enable virtual nursing, physician consultations, interpretive services and other hybrid care services. These solutions aim to alleviate the administrative workload of bedside staff while improving satisfaction for both healthcare providers and patients.The lucrativeness of the enhanced solution is expected to fetch higher members to TDOC and subsequently, boost its top line in the days ahead. In March, Teladoc enhanced its weight management capabilities in a bid to offer a personalized health and medical care program to keep an eye on minimizing care costs related to obesity and promoting healthy weight loss.TDOC’s Share Price Performance & Zacks RankShares of Teladoc have gained 68.8% in the past three months against the industry’s 12.3% decline. TDOC currently carries a Zacks Rank #3 (Hold). Image Source: Zacks Investment Research Stocks to ConsiderSome better-ranked stocks in the Medical space are Tenet Healthcare Corporation THC, LivaNova PLC LIVN and Select Medical Holdings Corporation SEM. Tenet Healthcare currently sports a Zacks Rank #1 (Strong Buy), and LivaNova and Select Medical carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.Tenet Healthcare’s earnings surpassed the Zacks Consensus Estimate in each of the last four quarters, the average surprise being 59.92%. The Zacks Consensus Estimate for THC’s 2024 earnings indicates a rise of 63%, while the consensus mark for revenues implies an improvement of 1.1% from the corresponding year-ago figures. The consensus estimate for THC’s earnings has moved 6.8% north in the past 30 days. Shares of Tenet Healthcare have declined 11.4% in the past three months. LivaNova’s earnings outpaced the Zacks Consensus Estimate in each of the trailing four quarters, the average surprise being 29.21%. The consensus estimate for LIVN’s 2024 earnings indicates a rise of 20.4% from the year-ago figure. The consensus mark for revenues indicates growth of 8.9% from the year-ago figure. The consensus estimate for LIVN’s earnings has moved 7% north in the past 30 days. Shares of LivaNova have gained 10.1% in the past three months. Select Medical’s earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, the average surprise being 24.18%. The consensus estimate for SEM’s 2024 earnings indicates a rise of 8.5%, while the consensus mark for revenues implies an improvement of 5.9% from the corresponding year-ago figures. The Zacks Consensus Estimate for SEM’s earnings has moved 6.4% north in the past 30 days. Shares of Select Medical have declined 40.8% in the past three months.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Tenet Healthcare Corporation (THC): Free Stock Analysis Report Select Medical Holdings Corporation (SEM): Free Stock Analysis Report Teladoc Health, Inc. (TDOC): Free Stock Analysis Report LivaNova PLC (LIVN): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf Ai

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Ai

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Teladoc Inc

Analysen zu Teladoc Inc

DatumRatingAnalyst
02.11.2018Teladoc BuyChardan Capital Markets
03.08.2018Teladoc BuyChardan Capital Markets
05.06.2018Teladoc BuyCanaccord Adams
15.03.2018Teladoc HoldDeutsche Bank AG
28.02.2018Teladoc BuyChardan Capital Markets
DatumRatingAnalyst
02.11.2018Teladoc BuyChardan Capital Markets
03.08.2018Teladoc BuyChardan Capital Markets
05.06.2018Teladoc BuyCanaccord Adams
28.02.2018Teladoc BuyChardan Capital Markets
08.12.2017Teladoc BuyDeutsche Bank AG
DatumRatingAnalyst
15.03.2018Teladoc HoldDeutsche Bank AG
18.09.2017Teladoc NeutralRobert W. Baird & Co. Incorporated
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Teladoc Inc nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"